13th Month Persistency Pressure
13th month persistency declined to 86% from 87% YoY due to economic pressure on Indian consumers and reduced high-ticket size sales. Management is closely monitoring this trend for potential EV walk negative variance.
Max Financial Services · risk themes across the available quarters.
Bear-case history
13th month persistency declined to 86% from 87% YoY due to economic pressure on Indian consumers and reduced high-ticket size sales. Management is closely monitoring this trend for potential EV walk negative variance.
Online AP remained flattish due to market volatility impacting ULIP demand. While management expects recovery through innovative product features combining guarantees and protection, the timeline remains uncertain.
Media speculation about regulatory changes to Section 35 provisions regarding insurance-non-insurance mergers remains unresolved despite management's view that the holding company structure poses no issues.
Regulatory changes on October 1st impacted fixed benefit health plans, causing degrowth in the health protection sub-segment that offset strong pure protection performance.
Despite being a flagship partnership, AXIS Bank grew only 7% in H1 vs 14% overall partnership growth. While management expects H2 improvement, the structural reasons for underperformance were not fully addressed. Multiple analysts probed this issue without receiving a satisfactory timeline for acceleration.
MFSL's GST impact of ₹268 crore on EV (110bps of opening EV) is ~2x peers (40-50bps) because their traditional participating products have higher renewal commissions structurally affected by ITC disallowance. This is a permanent product design disadvantage versus more ULIP-heavy competitors.
With ULIP already reduced from 60%+ to 50% at AXIS Bank, management explicitly stated no further reduction planned. Since ULIP was a margin dilutive product, this limits future mix-driven margin expansion. Any industry slowdown in equity markets could re-accelerate ULIP mix, pressuring margins.
Management acknowledged that opex growth (11%) has been in line with sales growth due to ongoing investments in agent expansion (1.42 lakh agents from 61,000 in FY22) and branch additions. The anticipated operating leverage from scale has not materialized yet, meaning margin upside is dependent on revenue growth sustaining.
Q3 13th-month persistency experienced pressure from a specific product category post-surrender regulations, where reduced surrender value created early lapse risk. Management acknowledged this was partially priced into assumptions.
New RBI circular (night before call) introduces additional misselling safeguards for bancassurance. While existing processes cover most requirements, incremental compliance changes may be needed at bank partner level.
~200bps margin headwind from GST remains unmitigated. Management targets complete offset but timeline of 'few quarters' creates earnings uncertainty if execution delays occur.
Pending IRDAI regulatory framework creates execution uncertainty. Exact structure details remain undisclosed, with management characterizing it as 'premature' to specify.